Identification of high-risk plaques by MRI and fluorescence imaging in a rabbit model of atherothrombosis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Hua, Ning ^a   Baik, Fred ^b   Pham, Tuan ^c   Phinikaridou, Alkystis ^d   Giordano, Nick ^a   Friedman, Beth ^e   Whitney, Michael ^e   Nguyen, Quyen T ^b   Tsien, Roger Y ^e,f   Hamilton, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Boston University   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e San Diego   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; GADOLINIUM CHELATE; MATRIX METALLOPROTEINASE; THROMBIN; FLUORESCENT DYE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; FLUORESCENCE IMAGING; IMAGE ANALYSIS; IN VIVO STUDY; MALE; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT MODEL; SENSITIVITY AND SPECIFICITY; THROMBOSIS; ANIMAL; ATHEROSCLEROSIS; CHEMISTRY; DIAGNOSTIC IMAGING; DISEASE MODEL; LIPID DIET; METABOLISM; PATHOLOGY; RABBIT; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELL-PENETRATING PEPTIDES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASES; OPTICAL IMAGING; PLAQUE, ATHEROSCLEROTIC; RABBITS; RADIOGRAPHY; ROC CURVE; THROMBIN;

EID: 84948703350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139833     Document Type: Article

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011 Feb 1; 123(4): e18-e209. doi: 10.1161/CIR.0b013e3182009701 PMID: 21160056
2. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 Sep; 32(9):2045-51. doi: 10.1161/ATVBAHA.108.179705 PMID: 22895665
3. Lusis AJ. Atherosclerosis. Nature. 2000 Sep 14; 407(6801):233-41. PMID: 11001066
4. Makowski MR, Wiethoff AJ, Blume U, Cuello F, Warley A, Jansen CHP, et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med. 2011 Mar; 17(3):383-8. doi: 10.1038/nm.2310 PMID: 21336283
5. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JGS, Weinreb DB, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA. 2007 Jan 16; 104(3):961-6. PMID: 17215360
6. Cai K, Caruthers SD, Huang W, Williams TA, Zhang H, Wickline SA, et al. MR molecular imaging of aortic angiogenesis. JACC Cardiovasc Imaging. 2010 Aug; 3(8):824-32. doi: 10.1016/j.jcmg.2010.03.012 PMID: 20705262
7. Olson ES, Whitney MA, Friedman B, Aguilera TA, Crisp JL, Baik FM, et al. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb). 2012 Jun; 4(6):595-605.
8. Lancelot E, Amirbekian V, Brigger I, Raynaud J-S, Ballet S, David C, et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):425-32. doi: 10.1161/ATVBAHA.107.149666 PMID: 18258820
9. Temma T, Ogawa Y, Kuge Y, Ishino S, Takai N, Nishigori K, et al. Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model. J Nucl Med. 2010 Dec; 51 (12):1979-86. doi: 10.2967/jnumed.110.081216 PMID: 21078793
10. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001 Aug 17; 89(4):305-16. PMID: 11509446
11. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002 Jul 1; 22(7):1065-74. PMID: 12117718
12. Yuan C, Hatsukami TS, O'Brien KD. High-Resolution magnetic resonance imaging of normal and atherosclerotic human coronary arteries ex vivo: discrimination of plaque tissue components. J Investig Med. 2001 Nov; 49(6):491-9. PMID: 11730084
13. Kim WY, Stuber M, Börnert P, Kissinger KV, Manning WJ, Botnar RM. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation. 2002 Jul 16; 106(3):296-9. PMID: 12119242
14. Phinikaridou A, Ruberg FL, Hallock KJ, Qiao Y, Hua N, Viereck J, et al. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model. Circ Cardiovasc Imaging. 2010 May; 3(3):323-32. doi: 10.1161/CIRCIMAGING.109.918524 PMID: 20194634
15. Phinikaridou A, Hua N, Pham T, Hamilton JA. Regions of Low Endothelial Shear Stress Co-localize with Positive Vascular Remodeling and Atherosclerotic Plaque Disruption: An in vivo MRI Study. Circ Cardiovasc Imaging. 2013 Jan 28.
16. Moreno PR, Purushothaman K-R, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006 May 9; 113(18):2245-52. PMID: 16684874
17. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994 Dec; 94(6):2493-503. PMID: 7989608
18. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002 Feb 22; 90(3):251-62. PMID: 11861412
19. Chatzizisis YS, Baker AB, Sukhova GK, Koskinas KC, Papafaklis MI, Beigel R, et al. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation. 2011 Feb 15; 123 (6):621-30. doi: 10.1161/CIRCULATIONAHA.110.970038 PMID: 21282495
20. Choudhary S, Higgins CL, Chen IY, Reardon M, Lawrie G, Vick GW, et al. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol. 2006 Oct; 26(10):2351-8. PMID: 16888239
21. Scholtes VPW, Johnson JL, Jenkins N, Sala-Newby GB, de Vries J-PPM, de Borst GJ, et al. Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy. J Am Heart Assoc. 2012 Dec; 1(6):e001040. doi: 10.1161/ JAHA.112.001040 PMID: 23316311
22. Borissoff JI, Spronk HMH, Heeneman S, Cate ten H. Is thrombin a key player in the "coagulation-atherogenesis" maze? Cardiovasc Res. 2009 Jun 1; 82(3):392-403. doi: 10.1093/cvr/cvp066 PMID: 19228706
23. Byrne CD, Wild SH. The Metabolic Syndrome. Wiley-Blackwell; 2011. 1 p.
24. Galis ZS, Kranzhöfer R, Fenton JW, Libby P. Thrombin promotes activation of matrix metalloproteinase- 2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997 Mar; 17(3):483-9. PMID: 9102166
25. Koo BH, Han JH, Yeom YI, Kim DS. Thrombin-dependent MMP-2 activity is regulated by heparan sulfate. Journal of Biological Chemistry. 2010.
26. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA. 2004 Dec 21; 101(51):17867-72. PMID: 15601762
27. Razavian M, Tavakoli S, Zhang J, Nie L, Dobrucki LW, Sinusas AJ, et al. Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation. J Nucl Med. 2011 Nov; 52(11):1795-802. doi: 10.2967/jnumed.111.092379 PMID: 21969358
28. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, et al. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol (Camb). 2009 Jun; 1(5-6):382-93.
29. Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, et al. Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides. J Biol Chem. 2010 Jul 16; 285(29):22532-41. doi: 10.1074/jbc.M110.138297 PMID: 20460372
30. Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009 May 1; 50(5):787-97. doi: 10.1194/jlr.M800460-JLR200 PMID: 19141434
31. Pasterkamp G, Borst C, Gussenhoven EJ, Mali WP, Post MJ, The SH, et al. Remodeling of De Novo atherosclerotic lesions in femoral arteries: impact on mechanism of balloon angioplasty. J Am Coll Cardiol. 1995 Aug; 26(2):422-8. PMID: 7608445
32. Saam T, Underhill HR, Chu B, Takaya N, Cai J, Polissar NL, et al. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol. 2008 Mar 11; 51(10):1014-21. doi: 10.1016/j.jacc.2007.10.054 PMID: 18325441
33. Phinikaridou A, Qiao Y, Giordano N, Hamilton JA. Detection of thrombus size and protein content by ex vivo magnetization transfer and diffusion weighted MRI. J Cardiovasc Magn Reson. 2012; 14:45. doi: 10.1186/1532-429X-14-45 PMID: 22731842
34. Yamashita A, Zhao Y, Zhao S, Matsuura Y, Sugita C, Iwakiri T, et al. Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions. Circ J. 2013; 77(10):2626-35. PMID: 23832535
35. Yamashita A, Asada Y. A rabbit model of thrombosis on atherosclerotic lesions. J Biomed Biotechnol. 2011; 2011:424929. doi: 10.1155/2011/424929 PMID: 21253503
36. Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995 Dec 1; 92(11):3183-93. PMID: 7586302
37. Tarkin JM, Joshi FR, Rudd JHF. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. Nature Publishing Group; 2014 Aug 1; 11(8):443-57.
38. Whitney M, Savariar EN, Friedman B, Levin RA, Crisp JL, Glasgow HL, et al. Ratiometric activatable cell-penetrating peptides provide rapid in vivo readout of thrombin activation. Angew Chem Int Ed Engl. 2013 Jan 2; 52(1):325-30. doi: 10.1002/anie.201205721 PMID: 23080482
39. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation. 2000 Feb 15; 101(6):598-603. PMID: 10673250
40. Yeon SB, Sabir A, Clouse M, Martinezclark PO, Peters DC, Hauser TH, et al. Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging: comparison with multislice computed tomography and quantitative coronary angiography. J Am Coll Cardiol. 2007 Jul 31; 50(5):441-7. PMID: 17662397
41. Yoo H, Kim JW, Shishkov M, Namati E, Morse T, Shubochkin R, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011 Dec; 17(12):1680-4. doi: 10.1038/ nm.2555 PMID: 22057345
42. Jaffer FA, Kim D-E, Quinti L, Tung C-H, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007 May 1; 115(17):2292-8. PMID: 17420353
43. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol. 1996 Jan; 148(1):121-8. PMID: 8546199
44. Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA. 2010 Mar 2; 107(9):4311-6. doi: 10.1073/pnas.0910283107 PMID: 20160077